Theravance Biopharma TBPH Stock
Theravance Biopharma Price Chart
Theravance Biopharma TBPH Financial and Trading Overview
| Theravance Biopharma stock price | 9.61 USD |
| Previous Close | 10.41 USD |
| Open | 10.41 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1000 |
| Day's Range | 10.28 - 10.47 USD |
| 52 Week Range | 7.53 - 12.03 USD |
| Volume | 662.5K USD |
| Avg. Volume | 545.67K USD |
| Market Cap | 600.52M USD |
| Beta (5Y Monthly) | 0.499295 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.4 USD |
TBPH Valuation Measures
| Enterprise Value | 410.45M USD |
| Trailing P/E | N/A |
| Forward P/E | -17.316666 |
| PEG Ratio (5 yr expected) | -0.71 |
| Price/Sales (ttm) | 12.364693 |
| Price/Book (mrq) | 1.6974351 |
| Enterprise Value/Revenue | 8.451 |
| Enterprise Value/EBITDA | -5.721 |
Trading Information
Theravance Biopharma Stock Price History
| Beta (5Y Monthly) | 0.499295 |
| 52-Week Change | 19.56% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.03 USD |
| 52 Week Low | 7.53 USD |
| 50-Day Moving Average | 11.16 USD |
| 200-Day Moving Average | 10.6 USD |
TBPH Share Statistics
| Avg. Volume (3 month) | 545.67K USD |
| Avg. Daily Volume (10-Days) | 553.39K USD |
| Shares Outstanding | 57.8M |
| Float | 24.04M |
| Short Ratio | 15.76 |
| % Held by Insiders | 11.23% |
| % Held by Institutions | 99.68% |
| Shares Short | 8.74M |
| Short % of Float | 29.34% |
| Short % of Shares Outstanding | 15.12% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1803.67% |
| Operating Margin (ttm) | -153.51% |
| Gross Margin | -12.65% |
| EBITDA Margin | -147.72% |
Management Effectiveness
| Return on Assets (ttm) | -10.42% |
| Return on Equity (ttm) | -781.33% |
Income Statement
| Revenue (ttm) | 48.57M USD |
| Revenue Per Share (ttm) | 0.69 USD |
| Quarterly Revenue Growth (yoy) | -21.099% |
| Gross Profit (ttm) | -12046000 USD |
| EBITDA | -71746248 USD |
| Net Income Avi to Common (ttm) | -74653000 USD |
| Diluted EPS (ttm) | -1.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 241.26M USD |
| Total Cash Per Share (mrq) | 4.17 USD |
| Total Debt (mrq) | 51.19M USD |
| Total Debt/Equity (mrq) | 13.82 USD |
| Current Ratio (mrq) | 9.981 |
| Book Value Per Share (mrq) | 6.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -172143008 USD |
| Levered Free Cash Flow (ttm) | 12.7M USD |
Profile of Theravance Biopharma
| Country | United States |
| State | N/A |
| City | George Town |
| Address | Ugland House |
| ZIP | KY1-1104 |
| Phone | N/A |
| Website | https://www.theravance.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 111 |
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Q&A For Theravance Biopharma Stock
What is a current TBPH stock price?
Theravance Biopharma TBPH stock price today per share is 9.61 USD.
How to purchase Theravance Biopharma stock?
You can buy TBPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theravance Biopharma?
The stock symbol or ticker of Theravance Biopharma is TBPH.
Which industry does the Theravance Biopharma company belong to?
The Theravance Biopharma industry is Biotechnology.
How many shares does Theravance Biopharma have in circulation?
The max supply of Theravance Biopharma shares is 48.56M.
What is Theravance Biopharma Price to Earnings Ratio (PE Ratio)?
Theravance Biopharma PE Ratio is now.
What was Theravance Biopharma earnings per share over the trailing 12 months (TTM)?
Theravance Biopharma EPS is -1 USD over the trailing 12 months.
Which sector does the Theravance Biopharma company belong to?
The Theravance Biopharma sector is Healthcare.
Theravance Biopharma TBPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Buyback Achievers DRBG | 2057.38 USD — |
-0.89
|
— — | 2057.25 USD — | 2057.65 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}